Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
NeoGenomics is transitioning from a commodity diagnostic provider to a comprehensive precision oncology platform. Read why ...
We enrolled 50 patients undergoing resection of newly diagnosed (n = 15) or recurrent (n = 35) GBM. CSF was collected intraoperatively via the subarachnoid space (n = 25) or lateral ventricle (n = 25) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results